We hypothesised that simultaneous targeting of two cancer cells’ defence mechanism – those against hypoxia and oxidative stress – by cooperative inhibiting carbonic anhydrase IX/XII and thioredoxin reductase, respectively, would have a synergistic effect. The gene discussed is PRDX5; the disease is cancer.